ATE184315T1 - Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt - Google Patents

Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt

Info

Publication number
ATE184315T1
ATE184315T1 AT93913035T AT93913035T ATE184315T1 AT E184315 T1 ATE184315 T1 AT E184315T1 AT 93913035 T AT93913035 T AT 93913035T AT 93913035 T AT93913035 T AT 93913035T AT E184315 T1 ATE184315 T1 AT E184315T1
Authority
AT
Austria
Prior art keywords
binding
endothelial cell
mediates
vap
lymphocytes
Prior art date
Application number
AT93913035T
Other languages
English (en)
Inventor
Sirpa Jalkanen
Marko Salmi
Original Assignee
Biotie Therapies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25404388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE184315(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotie Therapies Oy filed Critical Biotie Therapies Oy
Application granted granted Critical
Publication of ATE184315T1 publication Critical patent/ATE184315T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT93913035T 1992-06-09 1993-06-09 Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt ATE184315T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89535492A 1992-06-09 1992-06-09

Publications (1)

Publication Number Publication Date
ATE184315T1 true ATE184315T1 (de) 1999-09-15

Family

ID=25404388

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93913035T ATE184315T1 (de) 1992-06-09 1993-06-09 Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt

Country Status (14)

Country Link
EP (1) EP0656906B1 (de)
JP (2) JP3431922B2 (de)
KR (1) KR100268772B1 (de)
AT (1) ATE184315T1 (de)
AU (1) AU671837B2 (de)
CA (1) CA2137551C (de)
DE (1) DE69326347T2 (de)
DK (1) DK0656906T3 (de)
ES (1) ES2135480T3 (de)
FI (1) FI121176B (de)
GR (1) GR3031255T3 (de)
HU (1) HU217175B (de)
NZ (2) NZ299958A (de)
WO (1) WO1993025582A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1269829A (zh) * 1997-05-23 2000-10-11 拜奥泰治疗有限公司 有胺氧化酶活性的血管粘着蛋白－1
FI20020807A0 (fi) * 2002-04-29 2002-04-29 Biotie Therapies Oyj Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita
FI20061156A0 (fi) 2006-12-27 2006-12-27 Elina Kivi Uusia peptidejä
FI20075278A0 (fi) 2007-04-20 2007-04-20 Biotie Therapies Corp Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69406664T2 (de) * 1993-06-18 1998-06-04 Biotie Therapies Oy Zusammensetzungen und diagnostische verfahren unter verwendung von monoklonalen antikoerpern gegen cd44v6

Also Published As

Publication number Publication date
AU671837B2 (en) 1996-09-12
NZ253151A (en) 1997-03-24
HUT75824A (en) 1997-05-28
DE69326347D1 (de) 1999-10-14
JP3431922B2 (ja) 2003-07-28
FI20095269A (fi) 2009-03-16
JP2003180346A (ja) 2003-07-02
KR950701938A (ko) 1995-05-17
JP3500384B2 (ja) 2004-02-23
WO1993025582A1 (en) 1993-12-23
EP0656906B1 (de) 1999-09-08
GR3031255T3 (en) 1999-12-31
CA2137551C (en) 2002-03-26
JPH07507557A (ja) 1995-08-24
KR100268772B1 (ko) 2000-10-16
HU9403516D0 (en) 1995-02-28
DK0656906T3 (da) 1999-12-20
HU217175B (hu) 1999-12-28
FI121176B (fi) 2010-08-13
DE69326347T2 (de) 2000-02-24
AU4328193A (en) 1994-01-04
CA2137551A1 (en) 1993-12-23
EP0656906A1 (de) 1995-06-14
NZ299958A (en) 2000-07-28
ES2135480T3 (es) 1999-11-01

Similar Documents

Publication Publication Date Title
NO982062D0 (no) Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
DE69636748D1 (de) Bispezifischer antikörper zur effektiven behandlung von b-zell lymphomen und zellinien
ATE218387T1 (de) Antikörperreinigung
DE69531679D1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
KR950700779A (ko) 단백질의 정제방법(Protein purification)
DE69319662D1 (de) Monoklonale Antikörper gegen GP130-Protein
DE69429095T2 (de) Humanisierte antikoerper
EP1135415A4 (de) Humanisierte antikoerper gegen gamma-interferon
DK0673255T3 (da) Monoklonale antistoffer, som specifikt binder til vaskulært tumorendotel, og anvendelser deraf
ATE132197T1 (de) Monoklonale antikörper
ATE137533T1 (de) Monoklonale antikörper gegen melanom
DE69028513D1 (de) Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür
FI20095269A (fi) Lymfosyyttien sitoutumiseen vaikuttava ihmisen endoteelisolun molekyyli
DK0508993T3 (da) Farmaceutiske præparater indeholdende antigen-antistofkomplekser og anvendelse derfor
DK0493446T3 (da) Behandling af autoimmunsygdom.
DE3580382D1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
ATE143377T1 (de) Schimäre immunoglobuline für cd4-rezeptoren
SE8800886D0 (sv) Immunoglobulin conjugates
FR2571146B1 (fr) Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
ATE169332T1 (de) Monoklonaler antikörper gegen den extravillösen trophoblast
DE376770T1 (de) Verwendung von menschlichem immunoglobulin g oder fc-fragmente, wie vorbereitende arzneimittel fuer die verabreichung monoklonaler antikoerper an den menschen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification